BOTOX-UROLOGY

Drug Allergan Inc.
Total Payments
$1.2M
Transactions
354
Doctors
156
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $1.2M 354 156

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.2M 173 98.9%
Food and Beverage $12,228 178 1.0%
Travel and Lodging $944.53 3 0.1%

Payments by Type

Research
$1.2M
173 transactions
General
$13,172
181 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE AN ENHANCED INJECTION PARADIGM FOR ONABOTULINUMTOXINA BOTOX IN THE TREATMENT OF OVERACTIVE BLADDER IN PATIENTS WITH URINARY INCONTINENCE Allergan Inc. $1.1M 1
Multicenter, Double-Blind, Randomized, Placebo Controlled, Parallel-group, Study on the Safety and Pharmacodynamic Response of Botox in Subjects with Moderate to Severe Dynamic Glabellar Lines Allergan Inc. $29,553 2
DETERMINE VE CUTOFF RATIOS THAT PREDICT POST-PROCEDURE URINARY RETENTION REQUIRING CATHETERIZATION, AFTER TREATMENT WITH THERAPEUTIC DOSES OF BOTOX Allergan Inc. $23,642 0
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Single Treatment, 2-Stage, Dose finding Study Evaluating the Efficacy and Safety of Botox Intravesical Installation in Participants with Overactive Bladder and Urinary Incontinence. Allergan Inc. $13,950 0

Top Doctors Receiving Payments for BOTOX-UROLOGY — Page 2

Doctor Specialty Location Total Records
, M.D Urology Virginia Beach, VA $134.28 1
, MD Urology Santa Monica, CA $134.28 1
, MD Urology Cleveland, OH $134.28 1
, M.D Urology San Diego, CA $134.28 1
, MD Urology New York, NY $134.28 1
, M.D Urology Alhambra, CA $134.28 1
, M.D Urology Virginia Beach, VA $134.28 1
, MD Urology Norfolk, VA $134.28 1
, MD Obstetrics & Gynecology New Haven, CT $134.28 1
, M.D Urology Shreveport, LA $134.28 1
, M.D Urology West Hollywood, CA $134.28 1
, MD Urology Miramar, FL $134.28 1
, MD Urology Charleston, SC $134.28 1
, MB, BCH, FRCSI Urology Palo Alto, CA $134.28 1
, M.D Gynecology Tacoma, WA $130.82 1
, M.D Gynecology Kirkland, WA $130.82 1
, M.D Obstetrics & Gynecology Federal Way, WA $130.82 1
, MD Urogynecology and Reconstructive Pelvic Surgery Mountlake Terrace, WA $130.82 1
, MD Urology Edmonds, WA $130.82 1
Robert Moldwin Urogynecology and Reconstructive Pelvic Surgery New Hyde Park, NY $120.04 1
, M.D., PH.D Urogynecology and Reconstructive Pelvic Surgery Saint Louis, MO $112.77 1
Derrick Sanderson Obstetrics & Gynecology Williamsville, NY $109.79 1
, M.D Obstetrics & Gynecology Orlando, FL $109.79 1
, MD Urogynecology and Reconstructive Pelvic Surgery Durham, NC $109.79 1
, M.D Obstetrics & Gynecology Madison, WI $109.79 1

About BOTOX-UROLOGY

BOTOX-UROLOGY is a drug associated with $1.2M in payments to 156 healthcare providers, recorded across 354 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..

Payment data is available from 2017 to 2017. In 2017, $1.2M was paid across 354 transactions to 156 doctors.

The most common payment nature for BOTOX-UROLOGY is "Unspecified" ($1.2M, 98.9% of total).

BOTOX-UROLOGY is associated with 4 research studies, including "A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE AN ENHANCED INJECTION PARADIGM FOR ONABOTULINUMTOXINA BOTOX IN THE TREATMENT OF OVERACTIVE BLADDER IN PATIENTS WITH URINARY INCONTINENCE" ($1.1M).